More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$29.10B
EPS
8.91
P/E ratio
46.8
Price to sales
7.74
Dividend yield
0.249%
Beta
1.134087
Previous close
$416.42
Today's open
$417.03
Day's range
$415.08 - $420.66
52 week range
$223.83 - $438.27
show more
CEO
Eric M. Green
Employees
10800
Headquarters
Exton, PA
Exchange
New York Stock Exchange
Shares outstanding
69661036
Issue type
Common Stock
Healthcare
Biotechnology & Life Sciences
Top 50 High-Quality Dividend Growth Stocks For November 2026
I track 50 high-quality dividend growth stocks to identify favorable entry points, prioritizing long-term total return alongside a growing dividend stream. Forty stocks offer estimated future returns of at least 10%; 27 appear undervalued relative to historical free cash flow. ResMed leads with 41.60% estimated return potential; MarketAxess rose to fifth at 28.50% after a valuation upgrade and higher fair value estimate.
Seeking Alpha • Nov 14, 2026

Dividend Champion, Contender, And Challenger Highlights: Week Of November 15
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
Seeking Alpha • Nov 13, 2026

69 Dividend Champions Ranked By Quality Scores (November 2026)
I present 69 Dividend Champions with Dividend Safety scores of 8+ and rank them using my 9F Quality Scores system. Twenty-two featured Dividend Champions are undervalued, while 21 are overvalued. Forty-nine have quality scores ≥ 7.0, indicating high quality. Top candidates by style: BRO and BMI for growth; BRO, BMI, and RGLD (below $262) for total return; CTBI for income; CAT for past performance.
Seeking Alpha • Nov 7, 2026

West Pharmaceutical Services (WST) is a Great Momentum Stock: Should You Buy?
Does West Pharmaceutical Services (WST) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks Investment Research • Nov 5, 2026

West to Participate in Upcoming Investor Conference
EXTON, Pa., Nov. 4, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Jefferies Global Healthcare Conference on Wednesday, November 18, 2026, at 8:00 a.m. GMT in London, UK.
PRNewsWire • Nov 4, 2026

What West Pharmaceutical Services (WST) Said on Its Q3 Earnings Call
West Pharmaceutical Services NYSE: WST reported third-quarter results that exceeded its expectations, driven by continued demand for high-value product components, including those used in GLP-1 therapies and biologics. The company raised its full-year revenue and adjusted earnings outlook following the quarter.
MarketBeat • Oct 31, 2026

West Pharmaceutical Services, Inc. (WST) Q3 2026 Earnings Call Transcript
West Pharmaceutical Services, Inc. (WST) Q3 2026 Earnings Call Transcript
Seeking Alpha • Oct 29, 2026

West Reports Third-Quarter 2026 Results
Raising Full-Year Net Sales and Adjusted-Diluted EPS guidance EXTON, Pa., Oct. 29, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a leading provider of innovative, high-quality injectable solutions and services, today announced its financial results for the third quarter of 2026.
PRNewsWire • Oct 29, 2026

West Pharmaceutical Services (WST) Q3 Earnings and Revenues Top Estimates
West Pharmaceutical Services (WST) came out with quarterly earnings of $2.66 per share, beating the Zacks Consensus Estimate of $2.18 per share. This compares to earnings of $1.96 per share a year ago.
Zacks Investment Research • Oct 29, 2026

Compared to Estimates, West Pharmaceutical (WST) Q3 Earnings: A Look at Key Metrics
Although the revenue and EPS for West Pharmaceutical (WST) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks Investment Research • Oct 29, 2026

¹ Disclosures

Open an M1 investment account to buy and sell West Pharmaceutical Services Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.